Device
Hemolung Respiratory Assist System
Hemolung Respiratory Assist System is a medical device with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD
NCT03255057
completednot_applicable
Feasibility Study of the Hemolung Respiratory Assist System (Germany)
NCT01021605
completednot_applicable
Feasibility Study of the Hemolung Respiratory Assist System
NCT00987740
Clinical Trials (3)
Showing 3 of 3 trials
NCT03255057Not Applicable
Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD
NCT01021605Not Applicable
Feasibility Study of the Hemolung Respiratory Assist System (Germany)
NCT00987740Not Applicable
Feasibility Study of the Hemolung Respiratory Assist System
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3